USPTO serial 97715905
NIVELLA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRYANT, ALEXANDRIA N
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with NIVELLA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chungcheongbuk-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.TWO PRUDENTIAL PLAZA, 180 N. STETSON AVESUITE 4900CHICAGO, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 20, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 20, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 3, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 3, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 3, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 12, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 8, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 8, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 10, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2023 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2022 | NWAP | NEW APPLICATION ENTERED | — |